Cargando…
COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population
The Bacillus Calmette–Guérin (BCG) is a well-known vaccine with almost a century of use, with the apparent capability to improve cytokine production and epigenetics changes that could develop a better response to pathogens. It has been postulated that BCG protection against SARS-CoV-2 has a potentia...
Autores principales: | Garzon-Chavez, Daniel, Rivas-Condo, Jackson, Echeverria, Adriana, Mozo, Jhoanna, Quentin, Emmanuelle, Reyes, Jorge, Teran, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912416/ https://www.ncbi.nlm.nih.gov/pubmed/33513693 http://dx.doi.org/10.3390/vaccines9020091 |
Ejemplares similares
-
Identification of the Genotypes Circulating in the Ecuadorian Population Infected with the Hepatitis C Virus (HCV)
por: Moncayo, Miguel, et al.
Publicado: (2023) -
BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study
por: Thysen, Sanne Marie, et al.
Publicado: (2014) -
Mapping BCG vaccination coverage in Ethiopia between 2000 and 2019
por: Atalell, Kendalem Asmare, et al.
Publicado: (2022) -
Determinants of BCG vaccination coverage in Ethiopia: a cross-sectional survey
por: Tsehay, Asmamaw Ketemaw, et al.
Publicado: (2019) -
An Overview of Coverage of BCG Vaccination and Its Determinants Based on Data from the Coverage Survey in Zhejiang Province
por: Hu, Yu, et al.
Publicado: (2018)